Use the search parameters below to filter talks:

Calendar
Calendar

2010 - TTS International Congress (Vancouver)

Induction Immunosuppression
16 August 2010  /  12:14 - 13:14

Low Dose Rabbit Anti-Thymocyte Globulin Induction Therapy Results in Prolonged Selective CD4 T Cell Depletion Irrespective of Maintenance Immunosuppression

Presenter: Oleh Pankewycz, BUFFALO, United States

- Low Dose Rabbit Anti-Thymocyte Globulin Induction Therapy Results in Prolonged Selective CD4 T Cell Depletion Irrespective of Maintenance Immunosuppression

Presenter: Oleh Pankewycz, BUFFALO, United States

Low dose rabbit anti-thymocyte globulin induction in low risk renal transplant recipients: 8 years follow up.

Presenter: Mark Reza Laftavi, Buffalo, United States

- Low dose rabbit anti-thymocyte globulin induction in low risk renal transplant recipients: 8 years follow up.

Presenter: Mark Reza Laftavi, Buffalo, United States

Safety of rituximab as induction therapy in renal transplantation; results of an interim analysis

Presenter: M.W.F. van den Hoogen, Nijmegen, Netherlands

- Safety of rituximab as induction therapy in renal transplantation; results of an interim analysis

Presenter: M.W.F. van den Hoogen, Nijmegen, Netherlands

IL2 Blocker Induction in Living Related Renal Transplantation

Presenter: Gopal Basu, Vellore, India

- IL2 Blocker Induction in Living Related Renal Transplantation

Presenter: Gopal Basu, Vellore, India

Low dose ATG induction for older kidney transplant recipients (old for old); single centre experience over 4 years.

Presenter: Martin Nitschke, Lübeck, Germany

- Low dose ATG induction for older kidney transplant recipients (old for old); single centre experience over 4 years.

Presenter: Martin Nitschke, Lübeck, Germany

Basiliximab Induction versus Alemtuzumab Induction with Steroid Free Maintenance in Kidney Transplantation: Two-Year Outcomes

Presenter: Kannan Samy, Toledo, United States

- Basiliximab Induction versus Alemtuzumab Induction with Steroid Free Maintenance in Kidney Transplantation: Two-Year Outcomes

Presenter: Kannan Samy, Toledo, United States

Interleukin-2 Receptor Antagonist Induction Therapy Leads To Increased Tacrolimus Levels After Kidney Transplantation

Presenter: Sonia Lin, Kingston, United States

- Interleukin-2 Receptor Antagonist Induction Therapy Leads To Increased Tacrolimus Levels After Kidney Transplantation

Presenter: Sonia Lin, Kingston, United States

Alemtuzumab (Campath-1H) induction and prednisone – free maintenance immunotherapy in kidney transplant Hispanic patients

Presenter: Yenny Baez, Bogota, Colombia

- Alemtuzumab (Campath-1H) induction and prednisone – free maintenance immunotherapy in kidney transplant Hispanic patients

Presenter: Yenny Baez, Bogota, Colombia

Effect of Induction Therapy on Acute Rejection risk and Severity, Infection and Malignancy-related mortality in Renal Transplant recipients

Presenter: Rebecca Croke, Perth, Australia

- Effect of Induction Therapy on Acute Rejection risk and Severity, Infection and Malignancy-related mortality in Renal Transplant recipients

Presenter: Rebecca Croke, Perth, Australia

Relationship Between Rejection and Infection after T-Cell Depleting Induction Therapy

Presenter: Alan Farney, Winston-Salem, United States

- Relationship Between Rejection and Infection after T-Cell Depleting Induction Therapy

Presenter: Alan Farney, Winston-Salem, United States

Alemtuzumab Induction and Tacrolimus Maintenance Immunosuppression with and without Mycophenolic Acid in Kidney Transplantation

Presenter: Kannan Samy, Toledo, United States

- Alemtuzumab Induction and Tacrolimus Maintenance Immunosuppression with and without Mycophenolic Acid in Kidney Transplantation

Presenter: Kannan Samy, Toledo, United States

Epidemiology and Clinical Outcomes
16 August 2010  /  12:14 - 13:14

Kidney transplantation decreases rates of hospital separation for acute cardiac events but not cardiac failure compared to dialysis

Presenter: Shaundeep Sen, Adelaide, Australia

- Kidney transplantation decreases rates of hospital separation for acute cardiac events but not cardiac failure compared to dialysis

Presenter: Shaundeep Sen, Adelaide, Australia

A Mixed Treatment Comparison of Efficacy and Cardiometabolic Safety of Belatacept, Cyclosporine and Tacrolimus for Immunosuppression Therapy in Adult Renal Transplant Recipients

Presenter: Sarah Goring, Vancouver, Canada

- A Mixed Treatment Comparison of Efficacy and Cardiometabolic Safety of Belatacept, Cyclosporine and Tacrolimus for Immunosuppression Therapy in Adult Renal Transplant Recipients

Presenter: Sarah Goring, Vancouver, Canada

Trends in Estimated Glomerular Filtration Rate During Years 1 to 5 Post-Transplant, Data from the Predicting Outcomes in Renal Transplant (PORT) International Data Collaboration

Presenter: Jon Snyder, Minneapolis, United States

- Trends in Estimated Glomerular Filtration Rate During Years 1 to 5 Post-Transplant, Data from the Predicting Outcomes in Renal Transplant (PORT) International Data Collaboration

Presenter: Jon Snyder, Minneapolis, United States

The influence of Different Erythropoietin Regimes on Hemoglobin at 1 month post transplant

Presenter: Yuvaram Reddy, Chennai, India

- The influence of Different Erythropoietin Regimes on Hemoglobin at 1 month post transplant

Presenter: Yuvaram Reddy, Chennai, India

Older Patients Who Are Transplanted Have An Excellent Outcome Provided They Are Cardiologically Tested

Presenter: Michael Stephens, cardiff, Afghanistan

- Older Patients Who Are Transplanted Have An Excellent Outcome Provided They Are Cardiologically Tested

Presenter: Michael Stephens, cardiff, Afghanistan

Spousal Donor Renal Transplants-a viable option

Presenter: Alan Almeida, Mumbai, India

- Spousal Donor Renal Transplants-a viable option

Presenter: Alan Almeida, Mumbai, India

The long-term outcomes of kidney transplants with multiple renal arteries

Presenter: Jeong kye Hwang, Seoul, Korea

- The long-term outcomes of kidney transplants with multiple renal arteries

Presenter: Jeong kye Hwang, Seoul, Korea

The Evolving Outcomes of Kidney Transplant Recipients Over 70 Years of Age

Presenter: Islam Ghoneim, Cleveland, United States

- The Evolving Outcomes of Kidney Transplant Recipients Over 70 Years of Age

Presenter: Islam Ghoneim, Cleveland, United States

African American Race as a Risk Factor in Outcomes After Second and Third Kidney Transplantation

Presenter: Jennifer McGee, New Orleans, United States

- African American Race as a Risk Factor in Outcomes After Second and Third Kidney Transplantation

Presenter: Jennifer McGee, New Orleans, United States

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • www.onelambda.com
  • roche
  • sanofi